Related Experiment Video

Updated: Aug 10, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Aspects of hepatitis C virus infection relating to liver transplantation

Bruno Roche1, Didier Samuel

  • 1Centre Hépatobiliaire, Hôpital Paul Brousse, Villejuif, France.

European Journal of Gastroenterology & Hepatology
|March 16, 2006
PubMed

Insights

Hepatitis C virus (HCV) re-infection after liver transplantation is common and harms survival. Combination antiviral therapy shows promise for treating HCV graft injury, but optimal treatment strategies require further assessment.

Area of Science:

  • Hepatology
  • Virology
  • Transplantation Medicine

Background:

  • Hepatitis C virus (HCV) infection is a leading cause of end-stage liver disease and liver transplantation.
  • HCV recurrence post-transplantation is nearly universal and significantly reduces patient and graft survival.
  • Factors influencing HCV graft injury severity remain poorly understood.

Purpose of the Study:

  • To review the impact of HCV re-infection on liver transplant outcomes.
  • To evaluate current and emerging treatment strategies for post-transplantation HCV.
  • To identify areas for further research in managing HCV in transplant recipients.

Main Methods:

  • Literature review of studies on HCV recurrence after liver transplantation.
  • Analysis of data on the efficacy and safety of antiviral treatments.
  • Assessment of factors affecting HCV graft injury progression.

Main Results:

  • HCV re-infection significantly impairs long-term survival after liver transplantation.
  • Single-agent antiviral therapies (interferon, ribavirin) have shown limited efficacy.
  • Combination antiviral therapy has demonstrated sustained virological response in 25-35% of patients.

Conclusions:

  • HCV re-infection remains a critical challenge in liver transplantation.
  • Combination antiviral therapy offers a promising approach for managing HCV graft injury.
  • Further research is needed to define optimal indications, modalities, and duration for antiviral treatment.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...